Involvement of Cytochrome P-450 in n-Butyl Nitrite-Induced Hepatocyte Cytotoxicity

Document Type: Research Paper


1 Faculty of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Fars, Iran, 71345

2 Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada, M5S 2S2


      Addition of n-butyl nitrite to isolated rat hepatocytes caused an immediate glutathione depletion followed by an inhibition of mitochondrial respiration, inhi- bition of glycolysis and ATP depletion. At cytotoxic butyl nitrite concentrations, lipid  peroxidation  occurred  before  the  plasma  membrane  was  disrupted. Cytochrome P-450 inhibitors inhibited peroxynitrite formation and prevented butyl nitrite-induced mitochondrial respiration inhibition, ATP depletion, lipid peroxidation and plasma membrane disruption. However, glutathione depletion, S-nitroso-glutathione (GSNO) formation, or the inhibition of glycolysis was not affected by cytochrome P-450 inhibitors. Glutathione-depleted hepatocytes were resistant to butyl nitrite which suggests that cytotoxicity and peroxynitrite forma- tion results from GSNO formation. Peroxynitrite formation was also inhibited by reactive oxygen scavengers. These findings suggest that cytochrome P-450 iso- forms (particularly CYP2E1) act as a source of superoxide anion radicals in the formation of cytotoxic peroxynitrite from nitric oxide.


1. Introduction

     The vasodilator isoamyl nitrite has been used for years to relieve angina pectoris [1]. The structural isomer n-butyl nitrite (BN) is used as a drug of abuse to produce a euphoric- like state [2]. Both of these distinctive features have been attributed to the vasodilatory   action of nitric oxide (NO) formed during the metabolism of isoamyl nitrite [1], or when isoamyl nitrite is reduced by ascorbate or dithiothreitol [3]. Reports have also appeared suggesting that the abuse of nitrite inhalants is a cofactor in AIDS [4, 5], or Kaposi’s sarcoma in AIDS patients [6].

       BN has also been shown to be cytotoxic to lymphocytes [7]. Furthermore, T-lymphocyte blastogenesis and antibody responsiveness is decreased 90% when mice are exposed to BN at levels similar to those used by chronic users [8, 9]. Mortality was found to occur in rats exposed to ≥ 600 ppm BN vapours for 14 days and hepatocellular cytoplasmic vac- uolization was noted [10]. Previously, we showed that BN readily induces cytotoxicity in isolated hepatocytes. The   molecular   cytotoxic   mechanisms involved  the  immediate  formation  of  S- nitrosoglutathione (GSNO) as well as a con- comitant decrease in protein thiols, followed by a marked ATP depletion and finally lipid peroxidation   [11].   Furthermore,   GSH- depleted  hepatocytes were resistant to BN suggesting  that  GSNO  formed  in  normal hepatocytes  treated with BN contributes to ATP depletion, lipid peroxidation and cyto- toxicity. We also showed that the cytotoxici- ty of N-methyl-N’-nitro-N-nitrosoguanidine (MNNG) towards isolated hepatocytes could be attributed to GSNO formation and was prevented by  cytochrome P-450 inhibitors [12].  In  the  present  study,  we  have  also found that cytochrome P-450 inhibitors pre- vented BN cytotoxic effects including inhi- bition  of   mitochondrial  respiration,  ATP depletion,  lipid  peroxidation  and  plasma membrane disruption.


2. Materials and methods

2.1. Chemicals

      Collagenase  (from   Clostridium  his- tolyticum), HEPES and bovine serum albu- min    were   obtained   from   Boehringer- Mannheim    (Montreal,    P.Q.,    Canada). Trypan blue, metyrapone, imidazole and iso- niazid  were  obtained  from  the   Sigma Chemical  Co.   (St.   Louis,   MS,   USA). Desferoxamine was a gift from Ciba Geigy (Mississuga, ON, Canada). Isopropanol and toluene    were    purchased    from    BDH Chemicals (Toronto, ON, Canada) and ace- tone was obtained from Anachemia Canada Inc. (Toronto, ON, Canada). SKF 525A was obtained   from   Smith   Kline   Beecham Pharmaceuticals (King of Prussa, PA, USA) and HPLC grade solvents were purchased from Caledon (Georgetown, ON, Canada). n-Butyl nitrite was purchased from Aldrich Chemical Company (Milwaukee, WI, USA).

2-(4-Carboxyphenyl)-4,4,5,5-tetram - ethylimidazoline-3-oxide-1-oxyl  (carboxy- PTIO)   was  purchased  from  Calbiochem- Novabiochem Corp. (La Jolla, CA, USA). Other  chemicals were of the highest grade available.

2.2. Isolation and incubation of hepatocytes

       Hepatocytes  were  isolated  from  male Sprague-Dawley  rats  (250-300g),  main- tained on a standard chow diet, by collage- nase  perfusion of  the  liver,  as  previously described [13]. Cell viability was assessed by determining the percentage of the hepato- cytes which excluded trypan blue. Routinely, 85 to 90% of hepatocytes excluded trypan blue  immediately  after  isolation.  GSH- depleted  hepatocytes  were  prepared  by preincubating with n-bromoheptane as pre- viously described [14].

     Hepatocytes  (106   cells/ml)  were  suspended in Krebs-Henseleit buffer (pH 7.4) containing 12.5  mM  HEPES. All  incubations were performed in rotating, round bot- tomed flasks at 37 °C under a continuous flow of 95% O2 and 5% CO2 or 1% O2, 94% N2, and 5% CO2, where indicated. Reactions were started by the addition of BN. Aliquots of the incubation mixture were taken at various  time  points  for  biochemical analysis and cell viability determination.


2.3. Biochemical assays

      Lipid  peroxidation  was  measured  by treating 1 ml aliquots of hepatocytes with 1 ml 20% trichloroacetic acid, 1 ml 0.8% thiobarbituric acid, and the mixture was heated for 20 min. Samples were centrifuged for 5 min at 2500 g and the supernatant was mon- itored at 535 nm [15]. nATP levels in hepa tocytes were determined by alkaline extrac- tion and quantified  by HPLC using a C18 µBondapak reverse phase column (Waters Associates,   Milford,   MA,   USA)   [16]. Glycolysis  was  determined  by  measuring lactate formation from fructose. Lactate was measured by the formation of NADH from NAD+  by lactate dehydrogenase as previously described [17]. Total GSH and GSSG content of hepatocytes were measured by an HPLC procedure  using a µBondapak NH2 column, a Waters 6000 A solvent delivery system, a WISP 710A automatic injector and Data  Module  (Water Associates,  Milford, MA, USA) [18].

2.4. Peroxynitrite/NO2 assay

      The rate of peroxynitrite formation from BN was determined using the chemilumi- nescence method described by Radi et al. [19].  BN was added to 1 ml of hepatocytes (106 cells/ml) in the presence of 1 mM luminol and the relative light unit (RLU) was recorded   every    6    seconds,    using    a Luminometer LB 9501-Berthold Lumat.

2.5. Hepatocyte respiration measurement

      Hepatocyte respiration was measured at determined time points after the addition of BN to the incubation of hepatocytes, using a Clark-type oxygen electrode (Model 5300; Yellow-Spring Instrument Co., Inc.) in a 2 ml chamber maintained at 37 °C. Prior to oxygen consumption measurement, hepato- cytes (106 cells/ml) were kept at 37 °C in Krebs-Henseleit   buffer   plus   12.5   mM HEPES, pH 7.4 under 95% O2 and 5% CO2.

2.6. Statistics

      Values are means ± SD of three separate experiments    unless    otherwise    stated. Statistically significant differences between control   and   experimental  groups   were obtained using one way ANOVA.

3. Result

      BN cytotoxicity was dose-dependent and became marked above 100  µM  of  BN  at 95% O2. Plasma membrane bleb formation was seen as early as 30 min after 200 µM BN was added, with cytotoxicity commenc- ing  around  60  min  and  60%  cytotoxicity occurring at  about 120  min. However,  as shown in Table 1, BN cytotoxicity was prevented if the hepatocytes were preincubated for 15 min with the cytochrome P-4502E1 inhibitors    acetone,    and    2-hexanone. Similarly, the P-450 inhibitors phenylimida- zole,  SKF  525A,  metyrapone,  isoniazid, piperonyl butoxide, and imidazole also pre- vented or markedly delayed cytotoxicity. On the other hand, carboxy-PTIO, which converts NO to NO2 radical [20], increased BN cytotoxicity. At low oxygen concentrations, BN was five times less toxic as the ED50 for 2 hr determined at 1% O2 (1 mM) was five times higher than that determined at 95% O2 (0.2 mM).


Table 1. Effects of cytochrome P-450 inhibitors on BN cytotoxicity.

Note: Hepatocytes (106 cells/ml) were incubated in Krebs-Henseleit buffer (pH 7.4) at 37 °C under an atmosphere of 95% O2 and 5% CO2 with P-450 inhibitors for 20 min before addition of butyl nitrite. Cytotoxicity was determined as the percentage of cells taken up trypan blue.Values are shown as means ± SD of at least three separate experiments.a Significantly different from untreated cells (p< 0.001) bSignificantly different from butyl nitrite treated cells (p< 0.005)   c Carboxy-PTIO, a nitric oxide oxidizing agent, was not toxic at the concentration used.


     Lipid peroxidation, as measured by mal- ondialdehyde  formation,  occurred  only  at BN concentrations which were toxic to the cell. As shown in Table 2, lipid peroxidation was also prevented by the P-450 inhibitors SKF  525A,  phenylimidazole,  piperonyl butoxide, and metyrapone, if added before  BN but not if added 30 min after BN. Lipid peroxidation was increased by carboxy- PTIO and did not occur at a low 1% O2 concentration. The addition of BN to hepatocytes caused peroxynitrite formation as determined by luminol chemiluminescence. Furthermore, prior GSH depletion or low oxygen concentrations prevented peroxynitrite formation from BN. Antioxidants and P-450 inhibitors eg. Phenylimidazole decreased the rate of peroxynitrite formation(Figure 1).


Table 2. Effect of cytochrome P-450 inhibitors on BN-induced hepatocyte lipid peroxidation.

Note: Hepatocytes (106 cells/ml) were incubated in Krebs-Henseleit buffer (pH 7.4) at 37 °C under an atmosphere of 95% O2 and 5% CO2 with P-450 inhibitors for 20 min before addition of butyl nitrite. Values are shown as means (± SD) of at least three separate experiments.*MDA: Malondialdehyde.aSignificantly different from untreated cells (p < 0.01). bSignificantly different from butyl nitrite treated cells (p< 0.01).


Figure 1. Peroxynitrite formation from butyl nitrite. Butyl nitrite was added to 1 ml of hepatocytes (106 cells/ml) incubated with 1 mM luminol at 1 min and the relative light unit (RLU) was measured every 6 second. GSH-depleted hepatocytes were prepared by preincubation with bromoheptane; P-450 inhibition was achieved by preincubating hepatocytes with phenyl imidazole (0.3 mM) for 15 min. (_) No addition, (_) butyl nitrite 200 µM, (×) GSH depleted hepatocytes + butyl nitrite 200 µM, (_) P-450 inhibited hepatocytes + butyl nitrite 200 µM, (Æ) butyl nitrite 200 µM + morin 100 µM, (_) butyl nitrite 200 µM + hepatocytes incubated at 1% O2. Background chemiluminescence in GSH depleted or P-450 inhibited hepatocytes were not significantly different from control hepatocytes.

      Hepatocyte GSH levels were rapidly depleted upon addition of BN even if the hepatocytes were pretreated with P-450 inhibitors (data not shown).

       ATP depletion preceded cytotoxicity and  unlike lipid peroxidation, occurred with subtoxic  concentrations  of  BN  [11].  As shown in Table 3, ATP depletion was not prevented by antioxidants or desferoxamine but was prevented if the hepatocytes were preincubated with the P-450 inhibitors SKF525A,  phenylimidazole,  piperonyl  butox- ide, metyrapone or 2-hexanone. Hepatocyte ATP was not depleted at 1% O2  with 0.2 mM  BN,  even  though  initial ATP levels were lower than levels found at 95% O2.


Table 3. Effect of cytochrome P-450 inhibitors or reactive oxygen scavengers on butyl nitrite-induced ATP depletion.

 Note: Hepatocytes (106 cells/ml) were incubated in Krebs-Henseleit buffer (pH 7.4) at 37 °C under an atmosphere of 95% O2 and 5% CO2 with P-450 inhibitors or antioxidants for 15 min before addition of butyl nitrite. Values are shown as means (± SD) of three separate experiments. a Significantly different from untreated cells (p < 0.01).     bSignificantly different from butyl nitrite treated cells cells (p < 0.03).


      As  shown  in Table 4,  BN  (300  µM) decreased hepatocyte respiration to  about 50% and 31% of control value by 5 min and 30 min, respectively. Prior GSH depletion or P-450 inhibition prevented the inhibition of  hepatocyte respiration by  BN.  On  the other  hand,  the  NO-oxidizing  agent  car- boxy-PTIO [20] slightly increased the inhibition of mitochondrial respiration by BN. The rate of glycolysis was also markedly inhibited by BN; however, the inhibition of glycolysis was little affected by most P-450 inhibitors or carboxy-PTIO (Table 5).


Table 4. Effect of butyl nitrite on hepatocyte respiration.

Hepatocytes (106 cells/ml) were incubated in Krebs-Henseleit buffer, pH 7.4 under 95%  and 5% CO2. Oxygen uptake was measured with a Clark type electrode and a 2 ml chamber. GSH depleted hepatocytes were prepared by preincubating hepatocytes with bromoheptane. P-450 inhibition was achieved by preincubating hepatocytes with phenyl imidazole (300 µM) for 15 min.aSignificantly different from control. GSH depleted or P-450 inhibited hepatocytes were not significantly different from control.Carboxy-PTIO (100 µM) did not affect respiration of untreated hepatocytes.

Table 5. Effect of cytochrome P-450 inhibitors on butyl nitrite-induced inhibition of glycolysis.

Hepatocytes (106 cells/ml) were incubated in Krebs-Henseleit buffer, pH 7.4 at 37 °C under an atmosphere of  95% O 2 with P-450 inhibitors for 15 min before the addition of butyl nitrite. Fructose was added after butyl nitrite. Values are shown as means ± SD of at least three separate experiments. aSignificantly different from untreated cells (p < 0.001).    bSignificantly different from frucctose treated cells ( p < 0.001)

4. Discussion

      It has been previously shown that BN cytotoxicity  towards  isolated  hepatocytes involves ATP depletion, lipid peroxidation, and  plasma  membrane  disruption  [11]. Membrane disruption and lipid peroxidation but not ATP depletion were prevented by antioxidants.  However,  BN-induced  ATP depletion, cytotoxicity and lipid peroxidation could be prevented, if GSH was depleted before the addition of BN. This suggested that GSH was required for the cytotoxicity of BN. Similar results were also obtained for the NO donor MNNG [12].

     S-Nitrosoglutathione formation from organic nitrites has been shown [21] to be catalyzed by human GSH transferases particularly M1a-1a and A 1-1 but not P1-1 (eq. 1).RCH2ONO + GSH _ GSNO + RCH2OH (eq. 1).

      Furthermore, whilst stable in solution, GSNO slowly decomposes in the presence of GSH or ascorbate to form NO, apparently catalyzed by trace metals [22]. GSNO may thus act as an intracellular NO store which contributes to the cytotoxicity of BN. 2 GSNO _ 2 NO. + GSSG (eq. 2)

     The present study shows that cytochrome P-450 also contributes to the BN cytotoxic mechanisms as various P-450 inhibitors or substrates prevented cytotoxicity. Furthermore, P-450 inhibitors partially prevented the BN-induced inhibition ofmitochondrial respiration, ATP depletion, and lipid peroxidation. Other investigators have shown that sodium nitrite reacts with Fe2+-P-450 to form an unstable NO-Fe2+-P- 450 complex which is converted to a  NOFe2+- P-420 complex [23, 24]. Our results suggest that a similar unstable complex is also formed when BN or GSNO reacts with reduced cytochrome P-450 which suggests that reduced P-450 can reduce BN or GSNO to form nitric oxide (eq. 3, 4).

RCH2ONO + P-450-Fe2+ _ P-450-Fe3+ + NO. + RCH2O- (eq. 3)

GSNO + P-450-Fe2+ _ NO. + GS- + P-450-Fe3+ (eq. 4)

      BN also markedly increased peroxynitrite/NO2. formation in normal hepatocytes which was prevented if GSH depleted hepatocytes were used. This suggests that peroxynitrite formation from BN catalyzed by hepatocytes is dependent on GSNO formation and could be responsible for the cytotoxicity. Peroxynitrite has been shown to cause lipid peroxidation [25] and could therefore be responsible for BN-induced lipid peroxidation and cytotoxicity at high O2 concentrations. Lipid peroxidation could also be initiated by nitroxyl radicals or nitrogen dioxide formed from the peroxynitrite anion [26] as the NO oxidizing agent carboxy- PTIO, which converts NO to NO2.[20], further increased cytotoxicity and lipid peroxidation induced by BN. The high oxygen requirement for BN-induced lipid perox idation and ATP depletion further suggests that peroxynitrite could be the toxic species responsible for the inhibition of mitochondrial respiration and lipid peroxidation. Thus GSH  was  instantly  depleted  to  the  same extent upon addition of BN at 1% or 95% O2 (data not shown), whereas peroxynitrite formation, ATP depletion or lipid peroxidation did  not  occur  at  1%  but  at  95%  O2. Furthermore, the NO-oxidant carboxy-PTIO also increased the inhibition of mitochondrial respiration and ATP depletion induced by BN at 95% O2, further suggesting that an oxidation product of NO was responsible for the inhibition of mitochondrial respiration.

   Cytochrome  P-450  inhibitors,  reactive oxygen scavengers, or desferoxamine   partially inhibited peroxynitrite/NO2formation from BN. It is, therefore, more likely that cytochrome P-450 plays a role in BN cyto- toxicity b  y catalyzing the formation of per- oxynitrite (eq. 5, 6) or by acting as a source of superoxide radicals which are involved in the formation of cytotoxic peroxynitrite as shown in equation 7.

NO. + P-450-Fe2+_ P-450-Fe2+NO (eq. 5)

P450-Fe2+NO + O2 _ P-450-Fe3+ + ONOO-(eq. 6)   

NO. + O  .-_ ONOO-(eq. 7)


      It is possible that cytochrome P-450 activates peroxynitrite by catalyzing its conversion to NO2 which also readily causes lipid peroxidation [26]. Such a reaction (eq. 9) has also been suggested to explain the activation of peroxynitrite by peroxidases in which per- oxidase compound II is formed [27].

ONOOH + Fe3+ _ NO2 + Fe4+O (complex II) (eq. 8) BN markedly depletes hepatocytes ATP prior to lipid peroxidation even at noncytotoxic doses [11]. As hepatocyte respiration was partially inhibited when ATP depletion occurred, it is possible that ATP depletion

arose because: (a) NO complexed the ironsulfur proteins of the respiratory chain [28];

(b) peroxynitrite inhibited mitochondrial respiration by inactivating cytochrome C oxidase or succinate dehydrogenase [29, 30] or by inactivating aconitase of the citric acid cycle [31, 32]; and/or (c) GSNO (probably via NO+) inhibits glycolysis by inactivating glyceraldehyde-3-phosphate dehydrogenase by S-nitrosylating the active site which causes nonenzymatic auto-ADP-ribosylation by NAD+ [33-35]. Cytochrome P-450 inhibitors prevented mitochondrial respiration inhibition and ATP depletion induced by BN, without affecting the inhibition of glycolysis by BN, which suggests that ATP depletion primarily results from mitochondrial toxicity caused by peroxynitrite, whereas, glycolysis inhibition can be attributed to NO. Previously, it has been shown that prior hepatocyte GSH depletion prevented the inhibition of glycolysis by BN [11].

      In conclusion, a metabolite of BN, most likely peroxynitrite (or its breakdown products)formed from GSNO, is responsible for the inhibition of mitochondrial respiration,ATP depletion, lipid peroxidation and cytotoxicity induced by BN. Furthermore, cytochrome P-450 also seems to be involved in the reductive activation of BN or GSNO to form reactive metabolites eg. Peroxynitrite which causes lipid peroxidation that mediates BN cytotoxicity. Cytochrome P-450 inhibitors or substrates prevented the inhibition of hepatocyte respiration but did not prevent the inactivation of glycolysis by BN. It is interesting to speculate whether NO or GSNO inhibits glycolysis whereas peroxynitrite inhibits mitochondrial respiration.



[1]   Moncada S, Palmer RMJ, Higgs EA. The dis- covery of nitric oxide as the endogenous nitrova- sodilator. Hypertension 1988; 12: 365-372.

[2]   Sigell LT, Kapp FT, Fusaro GA, Nelson ED,Falck RS. Popping and snorting volatile nitrites:a current fad for getting high. Am J Psych 1978;135:  1216-1218. [3]   Gruetter   CA,   Kadowitz   PJ,   Ignarro   LJ.

Methylene blue inhibits coronary arterial relax- ation and guanylate cyclase activation by nitro- glycerin, sodium nitrite and amyl nitrite. Can J Physiol Pharmacol 1981; 59: 150-156.

[4]   Newell GR, Adams SC, Mansell PWA, Hersh EM.  Toxicity, immunosuppressive effects and carcinogenic potential of volatile nitrites: possi- ble    relationship    to    Kaposi’s    Sarcoma. Phrmacotherapy 1984; 4: 284-291.

[5]    Moss AR, Osmond D, Bacchetti P, Chermann JC, Barre-Sinoussi F, Carlson J. Risk factors for AIDS  and  HIV  seropositivity  in  homosexual men. Am J Epidemiol 1987; 125: 1035-1047.

[6]   Haverkos   HW,   Pinsky   PF,   Dortman   DP, Bregman,  DJ.  Disease  manifestation  among homosexual  men  with  acquired  immunodefi- ciency syndrome: a possible role of nitrites in Kaposi’s sarcoma. Sex Trans Dis 1985; 12: 203-208.

[7]   Hersh EM, Reuben JM, Bogerd H, Rosenblum M, Bielski M, Mansell PW, Rios A, Newell GR, Sonnenfeld, G. Effect of the recreational agent isobutyl  nitrite  on  human  peripheral  blood leukocytes and on in vitro interferon production. Cancer Res 1983; 43: 1365-1371.

[8]   Soderberg LSF, Barnett, JB. Exposure to inhaled isobutyl nitrite reduces T cell blastogenesis and antibody  responsiveness.  Fund  Appl  Toxicol 1991; 17: 821-824.

[9]   Soderberg LSF, Barnett JB, Chang LW. Inhaled isobutyl nitrite impairs T cell reactivity. Adv Exp Med Biol 1991; 288: 265-269.

[10] Gaworski CL, Aranyi C, Hall A, Levine BS, Jackson CD, Abdo KM. Prechronic inhalation toxicity  studies of isobutyl nitrite. Fund  Appl Toxicol 1992; 19: 169-175.

[11] Meloche BA, O’Brien PJ. S-nitrosyl glutathione mediated  hepatocyte  cytotoxicity. Xenobiotica

1993; 23: 863-871.

[12] Niknahad H, O’Brien PJ. (1995) Cytotoxicity induced  by  N-methyl-N’-nitro-N-nitrosoguani- dine  may  involve  S-nitrosyl  glutathione  and nitric oxide. Xenobiotica 1995; 25: 91-101.

[13] Moldeus P, Holberg J, Orrenius S. Isolation and use of liver cells. Methods in Enzymol 1978; 52:60-71.

[14] Khan S, O’Brien PJ. 1-Bromoalkanes as new potent nontoxic glutathione depletors in isolated hepatocytes.  Biochem Biophys Res  Commun1991; 179: 436-441.

[15] Smith MT, Thor H, Hartizell P, Orrenius S. The measurement of lipid peroxidation in isolated hepatocytes. Biochem Pharmacol 1982; 31: 19-26.

[16]   Stocchi   V,   Cucchiarini   L,   Magnani   M, Chiaranitini  PP,  Crescentini  G.  Simultaneous extraction and reverse-phase high-performance liquid  chromatographic determination of  ade- nine  and  pyridine  nucleotides  in  human  red blood cells. Anal Biochem 1984; 146: 118-124.

[17] Hohorst  HJ.  l-(+)-Lactate  determination  with lactic dehydrogenase and DPN. In: Bergmeyer HU, editor; Methods of enzymatic analysis. New York: Academic Press, 1965; 266-270.

[18] Reed DJ, Babson JR, Beatty PW, Brodie AE, Ellis WW, Potter DW. High-performance liquid chromatography analysis of nanomole levels of glutathione,  glutathione  disulfide,  and  related thiols and disulfides. Anal Bioshem 1980; 106:55-62.

[19] Radi R, Cosgrove TP, Beckman JS,  Freeman BA. Peroxynitrite-induced luminol chemilumi- nescence. Biochem J 1993; 290: 51-57.

[20] Yoshida K, Akaike T, Doi T, Sato K, Ijiri S, Suga M, Ando M, Maeda H. Pronounced enhance- ment  of  NO-dependent antimicrobial action by an  NO-oxidizing  agent,  imidazolineoxyl  N- oxide. Infect Immuonol 1993; 61: 3552-3555.

[21] Meyer DJ, Kramer H, Ketterer B. Human glu- tathione transferase catalysis of the formation of S-nitrosoglutathione from ogranic nitrites plus glutathione. FEBS Lett 1994; 351: 427-428.

[22] Mayer B, Schrammel A, Klatt P, Koesling D, Schmidt K. Peroxynitrite-induced accumulation of cyclic GMP in endothelial cells and stimula- tion  of  purified  soluble  guanylate  cyclase. Dependence on glutathione and possible role of S-nitrosation. J Biol Chem 1995; 270: 17355-17360.

[23] Kahl R, Wulff U, Netter KJ. Effect of nitrite on microsomal  cytochrome  P-450.  Xenobiotica

1978; 8: 359-364.

[24]O’Keefe DH, Ebel RE, Peterson JA. Studies of the oxygen binding site of cytochrome P450. Nitric oxide as a spin-label probe. J Biol Chem1978; 253: 3509-3516.

[25] Radi R, Beckman JS, Bush KM, Freeman BA.Peroxynitrite-induced membrane lipid peroxida- tion: the cytotoxic potential of superoxide and nitric      oxide.      Arch     Biochem     Biophys1991;288:481-487.

[26] Koppenol   WH,   Moreno   JJ,   Pryor   WA, Ischiropoulos H, Beckman JS. Peroxynitrite, a cloaked  oxidant  formed  by  nitric  oxide  and superoxide. Chem Res Toxicol 1992; 5: 834-842

 [27] Floris R, Piersma SR, Yang G, Jones P, Wever R.Interaction of myeloperoxidase with peroxyni- trite. A comparison with lactoperoxidase, horse- radish peroxidase and catalase. Eur J Biochem1993; 215: 267-275.

[28] Lancaster JR Jr, Hibbs JB Jr. EPR demonstration of iron-nitrosyl complex formation by cytotoxic activated macrophages. Proc Natl Acad Sci USA1990; 87: 1223-1227.

[29] Radi  R,  Rodriguez  M,  Castro  L,  Telleri  R.Inhibition of mitochondrial electron transport by peroxynitrite. Arch Biochem Biophys 1994; 308:89-95.

[30] Bolanos  JP,  Heales  SJ,  Land  JM,  Clark  JB.Effect of peroxynitrite on the mitochondrial res- piratory chain. J  Neurochem 1995; 64: 1965-1972.

[31] Hausladen A, Fridovich I. Superoxide and per- oxynitrite inactivate aconitase, but nitric  oxide does not: differential susceptibility of  neurons and astrocytes in primary cultures. J Biol Chem1994; 269: 29405-29408.

[32] Castro L, Rodriguez M, Radi R.  Aconitase  is readily inactivated by peroxynitrite,  but not by its precursor, nitric oxide. J  Biol  Chem 1994;269: 29409-29415.

[33] Brune B, Lapetina EG. Properties of a  novel nitric oxide-stimulated  ADP-ribosyltransferase. Arch Biochem Biophys 1990; 279: 286-290.

[34] Dimmeler S, Lottspeich F, Brune B. Nitric oxide causes ADP-ribosylation and inhibition of glyc- eraldehyde-3-phosphate dehydrogenase. J  Biol Chem 1992; 267: 16771-16774.

[35] Mohr S, Stamler JS, Brune B. Mechanism  of covalent  modification  of   glyceraldehyde-3- phosphate dehydrogenase at its active site thiol by   nitric   oxide,   peroxynitrite  and   related nitrosating agents.  FEBS Lett 1994; 348: 223-227